Recent Quarter Total Invested
$1.83 B
Recent Quarter Institutional Ownership Percentage
116.05%
Total Invested of Last Quarter
$1.67 B
Ownership Percentage of Last Quarter
104.64%
Edgewise Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 08/14/2024 | 15.02 M | $270.54 M | 0.00% | 17.15% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 8.91 M | $160.45 M | 0.00% | 10.17% |
| NOVO HOLDINGS A/S | 08/20/2024 | 6.34 M | $114.26 M | 100.00% | 7.25% |
| BLACKROCK INC. | 08/13/2024 | 6.02 M | $108.34 M | 16.43% | 6.87% |
| BAKER BROS. ADVISORS LP | 08/14/2024 | 5.84 M | $105.18 M | 0.00% | 6.67% |
| FMR LLC | 08/13/2024 | 4.78 M | $86.10 M | -24.90% | 5.46% |
| VANGUARD GROUP INC | 08/13/2024 | 4.51 M | $81.19 M | 12.22% | 5.15% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/15/2024 | 3.73 M | $67.20 M | 12.94% | 4.26% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2024 | 3.01 M | $54.15 M | 0.00% | 3.43% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2024 | 2.87 M | $51.77 M | 0.00% | 3.28% |
| JANUS HENDERSON GROUP PLC | 08/14/2024 | 2.61 M | $46.93 M | 44.42% | 2.98% |
| CITADEL ADVISORS LLC | 08/14/2024 | 2.35 M | $42.31 M | -13.61% | 2.68% |
| PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2024 | 2.33 M | $41.88 M | -4.94% | 2.66% |
| TCG CROSSOVER MANAGEMENT, LLC | 08/14/2024 | 2.27 M | $40.93 M | 0.00% | 2.60% |
| PERCEPTIVE ADVISORS LLC | 08/16/2024 | 1.86 M | $33.43 M | -19.97% | 2.12% |
| VR ADVISER, LLC | 08/14/2024 | 1.82 M | $32.75 M | 0.00% | 2.08% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.67 M | $30.13 M | 22.10% | 1.91% |
| STATE STREET CORP | 08/14/2024 | 1.67 M | $29.99 M | 37.44% | 1.90% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 1.62 M | $29.23 M | -7.16% | 1.85% |
| NEW LEAF VENTURE PARTNERS, L.L.C. | 08/14/2024 | 1.55 M | $27.98 M | 0.00% | 1.77% |
| VIKING GLOBAL INVESTORS LP | 08/14/2024 | 1.48 M | $26.68 M | -55.64% | 1.69% |
| BELLEVUE GROUP AG | 08/14/2024 | 1.43 M | $25.74 M | 100.00% | 1.63% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/15/2024 | 1.26 M | $22.70 M | -0.59% | 1.44% |
| ECOR1 CAPITAL, LLC | 08/14/2024 | 1.25 M | $22.52 M | 0.00% | 1.43% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 1.15 M | $20.63 M | 115.22% | 1.31% |
| AMERICAN CENTURY COMPANIES INC | 08/07/2024 | 860,067 | $15.49 M | 53.77% | 0.98% |
| ARTAL GROUP S.A. | 08/14/2024 | 811,718 | $14.62 M | 0.00% | 0.93% |
| BIOIMPACT CAPITAL LLC | 08/14/2024 | 740,661 | $13.34 M | 67.85% | 0.85% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 710,723 | $12.80 M | 16.89% | 0.81% |
| OPALEYE MANAGEMENT INC. | 08/14/2024 | 580,000 | $10.45 M | -12.78% | 0.66% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2024 | 574,517 | $10.35 M | -12.11% | 0.66% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 571,197 | $10.29 M | 14.89% | 0.65% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2024 | 528,594 | $9.52 M | 100.00% | 0.60% |
| NORTHERN TRUST CORP | 08/14/2024 | 508,691 | $9.16 M | 1.84% | 0.58% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 493,847 | $8.89 M | 4.43% | 0.56% |
| SOFINNOVA INVESTMENTS, INC. | 08/09/2024 | 475,691 | $8.57 M | 100.00% | 0.54% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 467,507 | $8.42 M | 56.21% | 0.53% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 436,608 | $7.86 M | 141.34% | 0.50% |
| WOODLINE PARTNERS LP | 08/14/2024 | 421,604 | $7.59 M | 4.07% | 0.48% |
| MARSHALL WACE, LLP | 08/14/2024 | 415,720 | $7.49 M | 661.16% | 0.47% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 362,576 | $6.53 M | -7.68% | 0.41% |
| CANDRIAM S.C.A. | 08/05/2024 | 329,000 | $5.93 M | 0.00% | 0.38% |
| D. E. SHAW & CO., INC. | 08/14/2024 | 311,476 | $5.61 M | -34.24% | 0.36% |
| DAFNA CAPITAL MANAGEMENT LLC | 08/14/2024 | 290,197 | $5.23 M | -5.23% | 0.33% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 272,794 | $4.91 M | 407.40% | 0.31% |
| KENNEDY CAPITAL MANAGEMENT LLC | 08/14/2024 | 272,071 | $4.90 M | -7.23% | 0.31% |
| STEMPOINT CAPITAL LP | 08/13/2024 | 271,057 | $4.88 M | 100.00% | 0.31% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 268,712 | $4.84 M | 26.59% | 0.31% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/13/2024 | 268,143 | $4.83 M | 100.00% | 0.31% |
| MORGAN STANLEY | 10/17/2024 | 249,974 | $4.50 M | -33.29% | 0.29% |
Edgewise Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of EWTX shares?
During the previous two years, 180 institutional investors and hedge funds held shares of Edgewise Therapeutics, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 15.02 M
RA CAPITAL MANAGEMENT, L.P.: 8.91 M
BlackRock Funding, Inc. /DE: 6.39 M
BAKER BROS. ADVISORS LP: 5.84 M
Novo Holdings A/S: 5.55 M
JANUS HENDERSON GROUP PLC: 4.56 M
-
What percentage of Edgewise Therapeutics, Inc. stock is owned by institutional investors?
116.05% of Edgewise Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at EWTX ?
Institutional investors have bought a total of 101.26 M shares in the last 24 months. This purchase volume represents approximately $3.24 B in transactions.